Stock to Watch: Enova International Inc. (NYSE: ENVA)

On Friday, Shares of Enova International Inc. (NYSE: ENVA) showed the bearish trend with a lower momentum of -2.08% to $23.58. The company traded total volume of 145.681K shares as contrast to its average volume of 269.11K shares. The company has a market value of $812.10M and about 34.44M shares outstanding.

Enova International (ENVA), a leading financial technology and analytics company offering consumer and small business loans and financing, recently declared financial results for the quarter ended March 31, 2019.

First Quarter 2019 Summary:

  • Total revenue of $293.0M in the first quarter of 2019 increased 15% from $254.0M in the first quarter of 2018. Gross profit margin was 52.6% in the first quarter of 2019, contrast to 57.3% in the first quarter of 2018.
  • Net income of $35.0M, or $1.02 per diluted share, in the first quarter of 2019 increased from $28.0M, or $0.81 per diluted share, in the first quarter of 2018.
  • First quarter 2019 adjusted EBITDA of $75.0M, a non-GAAP measure, increased from $68.0M in the first quarter of 2018.
  • Adjusted earnings of $40.0M, or $1.16 per diluted share, a non-GAAP measure, in the first quarter of 2019 increased from adjusted earnings of $35.0M, or $1.02 per diluted share, in the first quarter of 2018.
Related:  Kandi May Cause Tesla's Revenue To Fall In Q4 2020

Enova ended the first quarter of 2019 with unrestricted cash and cash equivalents of $93.0M. As of March 31, 2019, the company had total debt outstanding of $792.0M, which included $99.0M outstanding under Enova’s $350.0M securitization facilities. During the first quarter, Enova generated $221.0M of cash flow from operations.

Outlook:

For the second quarter of 2019, Enova anticipates total revenue of $265.0M to $285.0M; GAAP diluted earnings per share of $0.41 to $0.63, adjusted EBITDA of $45.0M to $55.0M and adjusted earnings per share of $0.48 to $0.70. For the full year 2019, Enova anticipates total revenue of $1.250B to $1.310B; GAAP diluted earnings per share of $2.83 to $3.48, adjusted EBITDA of $237.0M to $267.0M and adjusted earnings per share of $3.17 to $3.82.

Related:  Jumping Biotech Stock: Trevena (NASDAQ: TRVN)

The Company offered net profit margin of 6.70% while its gross profit margin was 47.80%. ROE was recorded as 21.90% while beta factor was 2.44. The stock, as of recent close, has shown the weekly upbeat performance of 1.77% which was maintained at 21.17% in this year.

Jack Dawkins

Finance and Tech Contributor